CORD-19:e847d433e7424152a9846673209cb73027415ecd / 389467-389749
Annnotations
CORD-19-Sentences
{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T3565","span":{"begin":0,"end":10},"obj":"Sentence"},{"id":"TextSentencer_T3566","span":{"begin":11,"end":282},"obj":"Sentence"},{"id":"T38697","span":{"begin":0,"end":10},"obj":"Sentence"},{"id":"T244","span":{"begin":11,"end":282},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Objective: The aim of this study was to evaluate diagnostic relevance of new artificial protein composed of 2 antigenic epitopes of the EBV EBNA1 and to develop and evaluate a screening enzyme immunoassay (EIA) for the detection of anti-EBNA1 IgG activity to EBV in serum specimens."}
Epistemic_Statements
{"project":"Epistemic_Statements","denotations":[{"id":"T528","span":{"begin":0,"end":282},"obj":"Epistemic_statement"}],"text":"Objective: The aim of this study was to evaluate diagnostic relevance of new artificial protein composed of 2 antigenic epitopes of the EBV EBNA1 and to develop and evaluate a screening enzyme immunoassay (EIA) for the detection of anti-EBNA1 IgG activity to EBV in serum specimens."}
CORD-19_Custom_license_subset
{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T27","span":{"begin":0,"end":10},"obj":"Sentence"},{"id":"T28","span":{"begin":11,"end":282},"obj":"Sentence"}],"text":"Objective: The aim of this study was to evaluate diagnostic relevance of new artificial protein composed of 2 antigenic epitopes of the EBV EBNA1 and to develop and evaluate a screening enzyme immunoassay (EIA) for the detection of anti-EBNA1 IgG activity to EBV in serum specimens."}
CORD-19-PD-UBERON
{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T285","span":{"begin":266,"end":271},"obj":"Body_part"}],"attributes":[{"id":"A285","pred":"uberon_id","subj":"T285","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"Objective: The aim of this study was to evaluate diagnostic relevance of new artificial protein composed of 2 antigenic epitopes of the EBV EBNA1 and to develop and evaluate a screening enzyme immunoassay (EIA) for the detection of anti-EBNA1 IgG activity to EBV in serum specimens."}